Novel cell-based assay for autoantibody detection in demyelination

A novel cell-based immunofluorescence assay (CBA) provides sensitive and specific detection of IgM antibodies against myelin-associated glycoprotein (MAG), as demonstrated in a study published in collaboration with scientists from the University of Verona and the Pediatric Research Institute in Padua, Italy. The Anti-MAG CBA is now available for research use*. Anti-MAG-IgM antibodies are markers for […]


Novel autoantibody against septin-3 discovered in neurological disease

The cytoskeleton protein septin-3 has been identified as a novel target antigen of autoantibodies in patients with paraneoplastic cerebellar ataxia. The new biomarker was discovered in a collaborative study between scientists at EUROIMMUN, the University of Heidelberg and further clinics in Germany. Septins are cytoskeletal proteins with multiple roles in cell division, cellular polarisation, morphogenesis


EUROIMMUN – a multinational company

At EUROIMMUN, worldwide over 1,800 colleagues of 35 different nationalities work hand in hand. EUROIMMUN fosters lasting and amicable relationships with subsidiaries and distributors in over 100 countries. We respect and value our employees, partners and friends – regardless of their nationality or religious orientation. We are extremely grateful to all colleagues who develop, produce

Scroll to Top